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LOCAL THERAPY WITH PYRIBENZAMINE HYDROCHLORIDE*·t 
MARION B. SULZBERGER, M.D., RUDOLF L. BAER M.D., AND HAROLD B. LEVIN, M.D. 
The preparations used to determine the effect of local therapy with Pyribenzamine hydro-
chloride were a 2% cream, a 5% cream, and, as a control, the blank water-miscible cream.t 
Both the medicated preparations and the blank control cream were prescribed for external 
application in a total of 90 patients with a variety of dermatoses. As a rule the patient 
applied the preparation three to four times daily. Of the 90 patients, 60 were followed in 
private practice and 30 in the clinic.** 
The cases can be divided into the following groups of dermatoses: 
Group I Atopic Dermatitis (Disseminated Neurodermatitis) 
40 cases (13 males; 27 females) 
Results: Of 40 cases, 2 showed transitory improvement in pruritus; 25 
showed no change; and 13 were made worse. 
Group II Dermatitis Eczematosa (Allergic Contact-Type) 
18 cases (9 males; 9 females) 
Results: Of 18 cases, 2 showed definite improvement in pruritus and clinical 
course; 2 showed transitory improvement; and 14 showed no change or 
were made worse. 
Group III Lichen Chronicus Simplex Circumscriptus (Vidal) (Circumscribed Neuro-
dermatitis) 
16 cases (4 males; 12 females) 
Results: Of 16 cases, 8 showed definite improvement in pruritus and clinical 
course; 4 showed transitory improvement in pruritus and clinical course; 
and 4 showed no change or were made worse. 
Group IV Pruritus Ani, Pruritus Vulvae 
5 cases (1 male; 4 females) 
Results: Of 5 cases, 2 showed transient improvement in pruritus but the 
clinical course was unchanged; and 3 were unchanged or made worse. 
Group V Miscellaneous Dermatoses (Psoriasis; Seborrheic Dermatitis; Dermatiti~ 
Herpetiformis; Circumscribed Scleroderma; Lupus Erythematosus, 
chronic discoid type; Chronic Discoid Lichenoid Exudative Dermatosis; 
Nummular Ezcema; Erythema Multiforme) 
11 cases (3 males; 8 females) 
Results: Of 11 cases, 2 showed transient improvement in pruritus and 9 
cases were unchanged or made worse. 
SIDE EFFECTS 
Of the total of 90 cases in which Pyribenzamine cream was used, in 5 cases the drug had to 
be stopped because of side reactions. Of these 5 patients, 2 were found to have an allergy 
of eczematous contact-type to Pyribenzamine, but no systemic effects otherwise; and these 
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two patients showed positive reactions to patch tests with 2% and 5% Pyribenzamine cream 
but no reaction to the blank water-miscible cream. 
Two patients developed vertigo, palpitation or "jittery" sensations within 2 to 4 days 
after applying 2% Pyribenzamine cream. These symptoms disappeared when the cream 
was discontinued. 
The fifth patient in this group had anosmia and loss of taste sensation which was first 
noticed about one week after using 2% Pyribenzamine cream and persisted for many months. 
In this particular case, it is not certain that the peculiar symptoms were due to the Pyri-
benzamine cream. 
DISCUSSION 
Pyribenzamine cream (2% or 5%) appears to be a good, clean and non-staining adjunct 
in the treatment of Lichen Chronicus Simplex. Its value in the other dermatoses treated 
is questionable. Contrary to the findings of Feinberg (1), beneficial effects were absent in 
our cases of atopic dermatitis, and seen in only the small minority of cases of such dermatoses 
as dermatitis eczematosa (contact type) and pruritus ani and vulvae. 
While the Pyribenzamine cream causes temporary burning and stinging when applied 
to fissured or broken skin, it did not cause primary skin irritation. However, in 2 of a series 
of 90 cases, there was evidence of a true allergic eczematous contact-type sensitization to 
Pyribenzamine. In 3 cases there was evidence of systemic side-effects, possibly due to 
absorption. 
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